1 2 3 32
Therapeutic Strategies in Dermatology

Lupus: Key Points

…s Lupus is a disease that presents across a broad spectrum of cutaneous and systemic manifestations. It may be cutaneous-only or systemic with cutaneous manifestations; some patients with systemic lupus do not have cutaneous involvement. Diagnostic…

Therapeutic Strategies in Dermatology

Kaposi’s Sarcoma: Overview

…. The following staging system may be used: Stage I: Localized cutaneous (fewer than 10 lesions, or one anatomic region); Stage II: Disseminated cutaneous (more than 10 lesions, or more than one anatomic area); Stage III: Visceral only; Stage IV: Cut…

Therapeutic Strategies in Dermatology

Vascular Birthmarks: Key Points

Key Points Vascular birthmarks are cutaneous vascular lesions present at, or shortly after, birth. They may be categorized as vascular tumors or vascular malformations. The term hemangioma has previously been used to describe many common, typicall…

Therapeutic Strategies in Dermatology

Cutaneous T-Cell Lymphoma/ Mycosis Fungoides: Overview

…ary team earlier rather than later to insure the best possible cutaneous response. Side effects are those of the agents employed, and patients must be carefully monitored for therapeutic complications. Patients with cutaneous T-cell lymphoma are comm…

Therapeutic Strategies in Dermatology

Leishmaniasis: Overview

…e infection was acquired. Leishmaniasis occurs in three forms: cutaneous, mucocutaneous, and visceral. Only the therapy of cutaneous leishmaniasis is discussed here. Old World Leishmaniasis The following therapy may not apply to disease acquired in A…

Therapeutic Strategies in Dermatology

Chondrodermatitis Nodularis Helicis: Key Points

…e ear, which often appears as a crusted ulceration mimicking a cutaneous malignancy. Diagnosis may be made by clinical exam and the symptom of pain, but biopsy of commonly performed to exclude cutaneous malignancies Treatment is aimed at protecting t…

Therapeutic Strategies in Dermatology

Cutaneous Allergic (Leukocytoclastic) Vasculitis: Overview

…ine use may be a trigger or exacerbating factor. Most cases of cutaneous LCV will require no or only brief courses of immunosuppressive therapy so, if symptoms persist, the concern for a systemic vasculitis would be enhanced. Cutaneous LCV may be ass…

1 2 3 32